U.S. Food and Drug Administration
Gaithersburg, United States
Elizabeth Duke, MD is a Pediatric Neuro-Oncologist serving as a Clinical Reviewer in the Division of Oncology 2 (DO2), in the Office of Oncologic Diseases (OOD), at the U.S. Food and Drug Administration (FDA). She received her M.D. from University of Maryland School of Medicine in 2014. She completed Pediatrics and Child Neurology residencies at Boston Children’s Hospital/Harvard Medical School, followed by a Pediatric Neuro-Oncology fellowship at Children’s National Hospital in Washington, D.C. Since joining FDA in 2020, Dr. Duke’s work has centered on the evaluation of investigational new drugs and marketing applications for drugs and biologics for the treatment of neuro-oncologic and pediatric solid tumors. She is engaged in regulatory research related to patient-reported outcomes and the use of expanded access in pediatric oncology.